Delivery Order SPE2DB22D9367-SPE2DB24FSX72

Award Date 5/6/24
Potential Completion Date 5/28/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of KYLEENA 19.5 MG SYSTEMS to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense (DoD). The contract, valued at $7,006.44, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with no set-aside designation, issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA valued...
The federal contract award is for the provision of KYLEENA 19.5 MG SYSTEMS to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $1,757.76, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order contract is a firm fixed-price arrangement, with an ultimate completion date of August 31, 2023. DMS Pharmaceutical Group Inc. holds a...
This federal contract award is for the delivery of KYLEENA 19.5 MG SYSTEMS pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $1,859.07, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order under the DLA's SPE2DB program, which is a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 and valid through November...
This federal contract award is for the delivery of KYLEENA 19.5 MG SYSTEMS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $29,296.00 and was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with no set-aside designation, issued under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the...
This federal contract award is for the delivery of KYLEENA 19.5 MG SYSTEMS to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract has a total ceiling value of $3,009.60 and is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has an ultimate completion date of January 30, 2024, and is not associated with any set-aside...
The U.S. Defense Logistics Agency (DLA) awarded a $4,815.36 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of the contraceptive device KYLEENA 19.5 MG SYSTEMS. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, valued up to $4,999,999, that DMS Pharmaceutical Group holds with DLA to provide a wide range of pharmaceutical products and medical...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,347.24, is a firm fixed-price delivery order for the supply of a pharmaceutical product, specifically the contraceptive device KYLEENA 19.5 MG SYSTEMS. The contract has an ultimate completion date of August 28, 2024. This award is part of a larger indefinite delivery contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,019.30 firm fixed-price delivery order is for the provision of 4564712004 KYLEENA 19.5 MG SYSTEMS, with a performance period ending on June 3, 2024. This award falls under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which...
This federal contract award, valued at $14,002.56, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order to supply the KYLEENA 19.5 MG SYSTEMS product. DMS Pharmaceutical Group Inc. holds a large indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This single-award vehicle, under the...
This federal contract award is for the delivery of Kyleena 19.5 mg systems to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The award, valued at $2,929.60, was made to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a completion date of November 30, 2023. DMS Pharmaceutical Group Inc. is a key supplier in the federal...
  • SPE2DB22D9367
    Indefinite Delivery Contract
  • SPE2DB22D9367-SPE2DB24FSX72
    Delivery Order

This federal contract award is for the delivery of KYLEENA 19.5 MG SYSTEMS pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $2,287.32, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is a firm fixed-price delivery order, with a completion date of May 28, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at $499,999,999 and valid through November 2026. The IDC enables the DLA to issue delivery orders for a broad range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities nationwide. This contract does not have a set-aside designation.

Generated 5/16/25, 12:20 PM